I am pleased to announce that the Japanese patent office has found our Amniobed patent application novel and non-obvious and we've been granted our patent in Japan!
This Japanese patent is now added to our portfolio of patents in the US and China giving us patent protection in three of the largest markets in the world. We are still pending in Europe and India and if we get further approvals there, it will truly solidify our patent portfolio across the globe, making us the true leader in the field of the artificial womb.
For those who have practiced their Japanese, here is the copy of the notice received today :)
Wefunder supports three different federal laws that allow startups to raise money legally. To comply with the law, Wefunder Advisors LLC and Wefunder Portal LLC (both owned by Wefunder Inc) also list startups depending on the regulation used.
Legal May 16th 2016
Wefunder Portal LLC
for 398 startups
Wefunder Advisors LLC
for 115 startups
for 3 startups
Curious how well the companies have done? Or how many raised follow-on financing?
Some fine print: 1) These numbers include startups currently live on Wefunder if they pass their minimum target. 2) Some startups use two different laws at the same time (i.e., Regulation D and Regulation Crowdfunding).
Join 700,522 investors who funded 485 startups with over $178 million1
wefunder.com/updates/136723-great-news-amniobed-japan-patent-awarded is managed by
Wefunder Portal LLC.
Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made.
Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA.
You may also view our Privacy Notice.